Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,225,213
-
Share change
-
+3,108,512
-
Total reported value
-
$7,969,000
-
Price per share
-
$1.28
-
Number of holders
-
24
-
Value change
-
+$3,927,773
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q1 2019
As of 31 Mar 2019,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,225,213 shares.
The largest 10 holders included
SPHERA FUNDS MANAGEMENT LTD., Point72 Asset Management, L.P., VANGUARD GROUP INC, PURA VIDA INVESTMENTS, LLC, Endurant Capital Management LP, LADENBURG THALMANN FINANCIAL SERVICES INC., Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, D.A. DAVIDSON & CO., and NORTHERN TRUST CORP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.